Ikarian Capital LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 11:03 am Sale |
2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Ikarian Capital LLC | 460,416 1.300% |
-1,289,627 (-73.69%) |
Filing |
| 2022-02-14 4:36 pm Sale |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Ikarian Capital LLC | 1,750,043 5.900% |
-86,502 (-4.71%) |
Filing |
| 2021-01-11 5:25 pm Purchase |
2020-08-03 | 13G | Milestone Pharmaceuticals Inc. MIST |
Ikarian Capital LLC | 1,836,545 6.200% |
1,836,545 (New Position) |
Filing |